Our findings agree with a previous report showing that OXA treatment stimulated the proliferation in pancreatic cancer cells by inhibiting apoptosis through the Akt/mTOR signaling pathway [41]. This evidence concerns the gene AKT1 and familial pancreatic carcinoma.